Literature DB >> 8727836

Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report.

P J Apostolides1, K A Greene, J M Zabramski, J W Fitzgerald, R F Spetzler.   

Abstract

We report two patients who had symptomatic cerebral vasospasm and cardiac failure after aneurysmal subarachnoid hemorrhage and who were treated successfully with intra-aortic balloon pump counterpulsation therapy. Both patients developed congestive heart failure and pulmonary edema while receiving postoperative hypertensive, hypervolemic, hemodilutional (Triple-H) therapy for symptomatic cerebral vasospasm. Both cases of cardiac failure were refractory to maximum pressor and inotropic infusions. Intra-aortic balloon pump counterpulsation was used to optimize cardiac performance to allow continuation of Triple-H therapy and to maintain adequate cerebral perfusion in an attempt to decrease the risk of cerebral ischemic complications. Both patients have had good long-term outcomes. These two cases illustrate the potential usefulness of the intra-aortic balloon pump as an adjunct to Triple-H therapy in patients with symptomatic cerebral vasospasm and cardiac failure. To our knowledge, this report documents the first clinical application of this adjunctive therapy for vasospasm after aneurysmal subarachnoid hemorrhage.

Entities:  

Mesh:

Year:  1996        PMID: 8727836     DOI: 10.1097/00006123-199605000-00042

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

Review 1.  Hemodynamic management of subarachnoid hemorrhage.

Authors:  Miriam M Treggiari
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

2.  Use of Intra-aortic- Balloon Pump Counterpulsation in Patients with Symptomatic Vasospasm Following Subarachnoid Hemorrhage and Neurogenic Stress Cardiomyopathy.

Authors:  Fawaz Al-Mufti; Nicholas Morris; Shouri Lahiri; William Roth; Jens Witsch; Iona Machado; Sachin Agarwal; Soojin Park; Philip M Meyers; E Sander Connolly; Jan Claassen
Journal:  J Vasc Interv Neurol       Date:  2016-06

Review 3.  Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature.

Authors:  Christos Lazaridis; Gustavo Pradilla; Paul A Nyquist; Rafael J Tamargo
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

Review 4.  Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage.

Authors:  Nicolas Bruder; Alejandro Rabinstein
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 5.  Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.

Authors:  Guilherme Dabus; Raul G Nogueira
Journal:  Interv Neurol       Date:  2013-10

6.  Cardiogenic shock with stunned myocardium during triple-H therapy treated with intra-aortic balloon pump counterpulsation.

Authors:  Fabio Silvio Taccone; Boris Lubicz; Michael Piagnerelli; Marc Van Nuffelen; Jean-Louis Vincent; Daniel De Backer
Journal:  Neurocrit Care       Date:  2008-09-23       Impact factor: 3.210

7.  Management of patients with stunned myocardium associated with subarachnoid hemorrhage.

Authors:  Rajan Jain; John Deveikis; Byron G Thompson
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

8.  Neurogenic Cardiac Injury.

Authors:  Nader M. Banki; Jonathan G. Zaroff
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-12

Review 9.  Aortic occlusion for cerebral ischemia: from theory to practice.

Authors:  David S Liebeskind
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

10.  Transcranial Doppler Waveforms During Intra-aortic Balloon Pump Counterpulsation for Vasospasm Detection After Subarachnoid Hemorrhage.

Authors:  Nicholas A Morris; Nathan Manning; Randolph S Marshall; E Sander Connolly; Jan Claassen; Sachin Agarwal; David J Roh; J Michael Schmidt; Soojin Park
Journal:  Neurosurgery       Date:  2018-09-01       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.